Subtype
Central Nervous System Hemangioblastoma
CI-CAN-00002139Explore in graph →
Non-malignant1 active trials
- NCIt
- C7007
Loading cancer entity…
Subtype
CI-CAN-00002139Explore in graph →
Clinical trials
3 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00052013 | Treatment of Von Hippel-Lindau (VHL)-Related Hemangioblastoma With PTK787/ZK 222584 | completed | Phase 2 | 11 | Novartis PharmaceuticalsINDUSTRY | 1 | Mar 6, 2017 | clinicaltrials |
Data updated 22 days agoSource updated Mar 6, 2017source: clinicaltrials